Senior In Vivo Oncopharmacology Lead for DC/IND

Genome Therapeutics in Cambridge is seeking a translational scientist to lead in vivo pharmacology, driving efficacy, PK/PD and safety profiling across oncology modalities. The role focuses on advancing small molecules and bioconjugates from hit-to-lead to DCs and INDs, guiding cross-functional teams to delivery of clinical candidates.

The successful candidate will design integrated strategies linking in vitro potency with in vivo engagement, supervise in vivo models (CDX/PDX/syngeneic/GEM), and

#J-18808-Ljbffr